SCHEDULE 13G/A: BlackRock Amends Stake in Semler Scientific, Discloses 3.6% Beneficial Ownership

BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 3.6% of Semler Scientific, Inc.'s common stock as of December 31, 2024.

Summary

• BlackRock, Inc. filed an Amendment No. 1 to Schedule 13G regarding its beneficial ownership in Semler Scientific, Inc.
• As of December 31, 2024, BlackRock, Inc. beneficially owns an aggregate of 372,405 shares of Semler Scientific, Inc. common stock.
• This beneficial ownership represents 3.6% of the total outstanding common stock of Semler Scientific, Inc.
• BlackRock, Inc. holds sole voting power over 369,515 shares and sole dispositive power over 372,405 shares.
• The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
• Several BlackRock subsidiaries, including Aperio Group, LLC, BlackRock Advisors, LLC, BlackRock Financial Management, Inc., BlackRock Fund Advisors, BlackRock Institutional Trust Company, National Association, and BlackRock Investment Management, LLC, are identified as relevant entities, none of which individually beneficially own 5% or greater of the outstanding shares.

Sentiment

Score: 5

Explanation: The document is a factual regulatory filing about beneficial ownership and does not contain subjective language or performance data to indicate strong positive or negative sentiment. It is neutral.

Positives

• BlackRock, Inc., a prominent institutional investor, maintains a significant stake in Semler Scientific, Inc., which can be interpreted as a continued vote of confidence in the company.
• The holding is explicitly stated to be in the ordinary course of business, indicating a passive investment strategy rather than an activist position aimed at influencing company control.

Negatives

• The reported beneficial ownership of 3.6% is below the 5% threshold that typically triggers an initial Schedule 13G filing, suggesting that BlackRock's stake in Semler Scientific, Inc. has decreased from a previous level that was 5% or more, or they are now below the threshold for continued reporting as a 5%+ owner.

Risks

• The document itself does not detail specific risks related to Semler Scientific, Inc.'s business operations, financial performance, or market position. It is solely a disclosure of beneficial ownership.
• The inherent market risk associated with holding equity securities applies to BlackRock's investment in Semler Scientific, Inc., as with any stock holding.

Future Outlook

NA

Industry Context

This filing is a routine regulatory disclosure by BlackRock, Inc., one of the world's largest asset managers, detailing its passive investment stake in Semler Scientific, Inc. Such Schedule 13G amendments are standard practice within the financial industry for institutional investors to comply with beneficial ownership reporting requirements as their holdings fluctuate.

Stakeholder Impact

• For shareholders of Semler Scientific, Inc., the continued holding by a major institutional investor like BlackRock, Inc. may be viewed positively as a sign of institutional confidence, although the reported percentage is below the 5% threshold for initial 13G filing, suggesting a potential reduction in stake from a previous higher level.

Key Dates

Keywords

Semler Scientific, BlackRock, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Investment Management